253 related articles for article (PubMed ID: 26495796)
1. Optical Imaging of Drug-Induced Metabolism Changes in Murine and Human Pancreatic Cancer Organoids Reveals Heterogeneous Drug Response.
Walsh AJ; Castellanos JA; Nagathihalli NS; Merchant NB; Skala MC
Pancreas; 2016 Jul; 45(6):863-9. PubMed ID: 26495796
[TBL] [Abstract][Full Text] [Related]
2. Functional Optical Imaging of Primary Human Tumor Organoids: Development of a Personalized Drug Screen.
Walsh AJ; Cook RS; Skala MC
J Nucl Med; 2017 Sep; 58(9):1367-1372. PubMed ID: 28588148
[TBL] [Abstract][Full Text] [Related]
3. Cellular Metabolic Heterogeneity In Vivo Is Recapitulated in Tumor Organoids.
Sharick JT; Jeffery JJ; Karim MR; Walsh CM; Esbona K; Cook RS; Skala MC
Neoplasia; 2019 Jun; 21(6):615-626. PubMed ID: 31078067
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic cancer-derived organoids - a disease modeling tool to predict drug response.
Frappart PO; Walter K; Gout J; Beutel AK; Morawe M; Arnold F; Breunig M; Barth TF; Marienfeld R; Schulte L; Ettrich T; Hackert T; Svinarenko M; Rösler R; Wiese S; Wiese H; Perkhofer L; Müller M; Lechel A; Sainz B; Hermann PC; Seufferlein T; Kleger A
United European Gastroenterol J; 2020 Jun; 8(5):594-606. PubMed ID: 32213029
[TBL] [Abstract][Full Text] [Related]
5. Metabolic Imaging of Head and Neck Cancer Organoids.
Shah AT; Heaster TM; Skala MC
PLoS One; 2017; 12(1):e0170415. PubMed ID: 28099487
[TBL] [Abstract][Full Text] [Related]
6. Personalizing pancreatic cancer organoids with hPSCs.
Zhang HC; Kuo CJ
Nat Med; 2015 Nov; 21(11):1249-51. PubMed ID: 26540385
[No Abstract] [Full Text] [Related]
7. Metabolic Heterogeneity in Patient Tumor-Derived Organoids by Primary Site and Drug Treatment.
Sharick JT; Walsh CM; Sprackling CM; Pasch CA; Pham DL; Esbona K; Choudhary A; Garcia-Valera R; Burkard ME; McGregor SM; Matkowskyj KA; Parikh AA; Meszoely IM; Kelley MC; Tsai S; Deming DA; Skala MC
Front Oncol; 2020; 10():553. PubMed ID: 32500020
[TBL] [Abstract][Full Text] [Related]
8. Predictive imaging of chemotherapeutic response in a transgenic mouse model of pancreatic cancer.
Wang P; Yoo B; Sherman S; Mukherjee P; Ross A; Pantazopoulos P; Petkova V; Farrar C; Medarova Z; Moore A
Int J Cancer; 2016 Aug; 139(3):712-8. PubMed ID: 26996122
[TBL] [Abstract][Full Text] [Related]
9. Quantitative optical imaging of primary tumor organoid metabolism predicts drug response in breast cancer.
Walsh AJ; Cook RS; Sanders ME; Aurisicchio L; Ciliberto G; Arteaga CL; Skala MC
Cancer Res; 2014 Sep; 74(18):5184-94. PubMed ID: 25100563
[TBL] [Abstract][Full Text] [Related]
10. Claudin-4-targeted optical imaging detects pancreatic cancer and its precursor lesions.
Neesse A; Hahnenkamp A; Griesmann H; Buchholz M; Hahn SA; Maghnouj A; Fendrich V; Ring J; Sipos B; Tuveson DA; Bremer C; Gress TM; Michl P
Gut; 2013 Jul; 62(7):1034-43. PubMed ID: 22677720
[TBL] [Abstract][Full Text] [Related]
11. Differences in Nanoparticle Uptake in Transplanted and Autochthonous Models of Pancreatic Cancer.
Tao Z; Muzumdar MD; Detappe A; Huang X; Xu ES; Yu Y; Mouhieddine TH; Song H; Jacks T; Ghoroghchian PP
Nano Lett; 2018 Apr; 18(4):2195-2208. PubMed ID: 29533667
[TBL] [Abstract][Full Text] [Related]
12. The effect of extracellular matrix on the precision medicine utility of pancreatic cancer patient-derived organoids.
Lumibao JC; Okhovat SR; Peck KL; Lin X; Lande K; Yomtoubian S; Ng I; Tiriac H; Lowy AM; Zou J; Engle DD
JCI Insight; 2024 Jan; 9(1):. PubMed ID: 38051586
[TBL] [Abstract][Full Text] [Related]
13. Structural and Functional Characterization of Human Stem-Cell-Derived Retinal Organoids by Live Imaging.
Browne AW; Arnesano C; Harutyunyan N; Khuu T; Martinez JC; Pollack HA; Koos DS; Lee TC; Fraser SE; Moats RA; Aparicio JG; Cobrinik D
Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3311-3318. PubMed ID: 28672397
[TBL] [Abstract][Full Text] [Related]
14. Organoid models of human and mouse ductal pancreatic cancer.
Boj SF; Hwang CI; Baker LA; Chio II; Engle DD; Corbo V; Jager M; Ponz-Sarvise M; Tiriac H; Spector MS; Gracanin A; Oni T; Yu KH; van Boxtel R; Huch M; Rivera KD; Wilson JP; Feigin ME; Öhlund D; Handly-Santana A; Ardito-Abraham CM; Ludwig M; Elyada E; Alagesan B; Biffi G; Yordanov GN; Delcuze B; Creighton B; Wright K; Park Y; Morsink FH; Molenaar IQ; Borel Rinkes IH; Cuppen E; Hao Y; Jin Y; Nijman IJ; Iacobuzio-Donahue C; Leach SD; Pappin DJ; Hammell M; Klimstra DS; Basturk O; Hruban RH; Offerhaus GJ; Vries RG; Clevers H; Tuveson DA
Cell; 2015 Jan; 160(1-2):324-38. PubMed ID: 25557080
[TBL] [Abstract][Full Text] [Related]
15. Development of organoid-based drug metabolism model.
Park E; Kim HK; Jee J; Hahn S; Jeong S; Yoo J
Toxicol Appl Pharmacol; 2019 Dec; 385():114790. PubMed ID: 31678242
[TBL] [Abstract][Full Text] [Related]
16. Cancer-associated fibroblasts in pancreatic adenocarcinoma.
Pan B; Liao Q; Niu Z; Zhou L; Zhao Y
Future Oncol; 2015 Sep; 11(18):2603-10. PubMed ID: 26284509
[TBL] [Abstract][Full Text] [Related]
17. Curcumin Induces Pancreatic Adenocarcinoma Cell Death Via Reduction of the Inhibitors of Apoptosis.
Díaz Osterman CJ; Gonda A; Stiff T; Sigaran U; Valenzuela MM; Ferguson Bennit HR; Moyron RB; Khan S; Wall NR
Pancreas; 2016 Jan; 45(1):101-9. PubMed ID: 26348467
[TBL] [Abstract][Full Text] [Related]
18. Organoid Culture of Isolated Cells from Patient-derived Tissues with Colorectal Cancer.
Xie BY; Wu AW
Chin Med J (Engl); 2016 Oct; 129(20):2469-2475. PubMed ID: 27748340
[TBL] [Abstract][Full Text] [Related]
19. K-Ras-driven pancreatic cancer mouse model for anticancer inhibitor analyses.
Cook N; Olive KP; Frese K; Tuveson DA
Methods Enzymol; 2008; 439():73-85. PubMed ID: 18374157
[TBL] [Abstract][Full Text] [Related]
20. Patient-derived organoids, creating a new window of opportunities for pancreatic cancer patients.
Sandhya S; Hogenson TL; Fernandez-Zapico ME
EMBO Mol Med; 2022 Apr; 14(4):e15707. PubMed ID: 35285156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
